MyoKardia

Read more
Tassos Gianakakos's photo - CEO of MyoKardia

CEO

Tassos Gianakakos

CEO Approval Rating

94/100

Founded:

2012

Status:

PublicSubsidiary of Bristol Myers Squibb CoNASDAQMYOK

MYOKARDIA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Tenaya has been one of MyoKardia's top competitors. Tenaya was founded in 2016, and is headquartered in South San Francisco, California. Tenaya competes in the Biotechnology industry. Tenaya generates $29.1M less revenue vs. MyoKardia.

Cytokinetics is a top competitor of MyoKardia. Cytokinetics is a Public company that was founded in South San Francisco, California in 1998. Like MyoKardia, Cytokinetics also competes in the Biotechnology industry. Cytokinetics has 19 more employees vs. MyoKardia.

Renovacor is perceived as one of MyoKardia's biggest rivals. Renovacor was founded in 2012, and its headquarters is in Greenwic, Connecticut. Like MyoKardia, Renovacor also operates in the Biotechnology field. Renovacor has 125 fewer employees than MyoKardia.

MyoKardia Quarterly and Annual Revenue

Coming soon for MyoKardia!

Annual Revenue

$33.6M

MyoKardia's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 71.8M.

MyoKardia Acquisitions

No recent acquisitions found related to MyoKardia

MyoKardia Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Oct 2015
$54.4M
-
Series B
Apr 2015
$46M
Equity
Jul 2014
$10M
Equity
Sep 2012
$4M
-
Equity
Aug 2012
$459
-

MyoKardia Investments

No recent investments found related to MyoKardia

MyoKardia News

MyoKardia Press Releases

Social Media

MyoKardia Headquarters

1000 Sierra Point Parkway

Brisbane, California94005

650-741-0900

Driving Directions »

Trending Companies

MyoKardia Summary

ABOUT

Overview

MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases. MyoKardia was founded in 2012. MyoKardia's headquarters is located in Brisbane, California, USA 94005. It has raised 114....

CEO

MyoKardia's CEO, Tassos Gianakakos, currently has an approval rating of 94%. MyoKardia's primary competitors are Tenaya, Cytokinetics & Renovacor.

Frequently Asked Questions about MyoKardia

  1. When was MyoKardia founded?

    MyoKardia was founded in 2012
  2. Who is MyoKardia's CEO?

    MyoKardia's CEO is Tassos Gianakakos
  3. How much revenue does MyoKardia generate?

    MyoKardia generates $33.6M in revenue
  4. How much funding does MyoKardia have?

    MyoKardia has historically raised $114.4M in funding
  1. Where is MyoKardia's headquarters?

    MyoKardia's headquarters is in Brisbane California, USA
  2. How many employees does MyoKardia have?

    MyoKardia has 165 employees
  3. What sector does MyoKardia operate in?

    MyoKardia is in Biotechnology, Pharmaceuticals
  4. Who are MyoKardia's competitors?

    MyoKardia's top competitors are Tenaya, Cytokinetics, Renovacor